ArticleDiagnostics (Basel, Switzerland)2023

Risk of Secondary Cancer after Adjuvant Tamoxifen Treatment for Ductal Carcinoma In Situ: A Nationwide Cohort Study in South Korea.

Dooreh Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.